By Allison Sit The FDA has approved Olumiant (baricitinib) as a first-in-disease systemic treatment for adults with severe alopecia areata. Olumniant is a once-daily, oral JAK inhibitor. "People with alopecia…
Read More
By Allison Sit The Journal of Drugs in Dermatology is celebrating its 20th anniversary this month as the journal continues to make news. Healio covered several JDD studies in the…
Read More
By Allison Sit A national survey of more than 500 adults with plaque psoriasis who are on topical treatments revealed insights into the emotional impact of the disease and challenges…
Read More
By Allison Sit The European Academy of Dermatology and Venerology (EADV) has released a statement on Russia’s invasion of Ukraine, calling for solidarity with those affected by the conflict. “The…
Read More
